CN
News & Reports

News and Reports

Select year

2024 2023 2022 2021 2020 Earlier
shown/page
5
5 10 15 20

2019.12.03

National Medical Products Administration (NMPA) Approves Chipscreen Bioscience's Chidamide (Epidaza) for Breast Cancer Indication
National Medical Products Administration (NMPA) Approves Chipscreen Bioscience's Chidamide (Epidaza) for Breast Cancer Indication

Full text

2019.10.09

Chipscreen and Novogene enter a strategic partnership for companion diagnostics development
Chipscreen and Novogene enter a strategic partnership for companion diagnostics development

Full text

2019.09.20

Chipscreeen Biosciences’s Original New Drug Bilessglu® (for Type 2 Diabetes): Commercialization Application Accepted
Chipscreeen Biosciences’s Original New Drug Bilessglu® (for Type 2 Diabetes): Commercialization Application Accepted

Full text

2018.05.30

Good News! CHIPSCREEN BIOSCIENCES Is Approved to Be Provincial Engineering Research Center
Good News! CHIPSCREEN BIOSCIENCES Is Approved to Be Provincial Engineering Research Center

Full text

2018.05.19

The CHIPSCREEN BIOSCIENCES was invited to participate in celebration of 40th anniversary of WHO Uppsala Monitoring Center
The CHIPSCREEN BIOSCIENCES was invited to participate in celebration of 40th anniversary of WHO Uppsala Monitoring Center

Full text
Media contact

Media contact

  • Media contact

    （+86）0755-36993500

  • Media contact

    pr@chipscreen.com